Single Use Probes & Sensors Market Size, Share, and Industry Analysis, By Type (pH Sensors/Probes, Pressure Sensors/Probes, Temperature Sensors/Probes, Conductivity Sensors/Probes, Oxygen & CO2 Sensors/Probes, Flow Sensors/Probes, and Others), By Workflow (Upstream and Downstream), By End User (Biopharmaceutical/Pharmaceutical Companies, CMOs & CROs, and Others), and Regional Forecast, 2024-2032

Single use sensors are also known as single use probes. These devices are single-use or disposable devices utilized in the biopharmaceutical processes. These devices are designed to monitor and control various parameters, including pH, pressure, temperature, dissolved oxygen, conductivity, and biomass in bioreactors and other bioprocessing equipment.

The biopharmaceutical industry is widely utilizing single-use products due to their various advantages, such as lower cross-contamination risks, faster turnaround times, and limited operational costs. Single-use bioprocessing probes and sensors contribute to this trend by offering disposable and pre-sterilized choices, eliminating the necessity for cleaning and validation associated with reusable probes and sensors. The increasing market value of single use bioprocessing probes and sensors is fueled by the convenience and cost-effectiveness they offer, driving demand for these technologies.

Furthermore, due to factors such as the increasing geriatric population, growing prevalence of chronic diseases, and advances in healthcare infrastructure, the demand for biopharmaceutical products is increasing steadily across the globe.

• For instance, as per the data provided by the National Center for Chronic Disease Prevention and Health Promotion in February 2024, the U.S. Department of Health and Human Services identified that nearly 129 million people in the U.S. have at least one major chronic disease (e.g., cancer, cardiovascular disease, diabetes, and obesity).

Biopharmaceuticals, such as vaccines, monoclonal antibodies, and cell therapies, depend on precise and efficient bioprocessing technologies for their manufacture. Single-use bioprocessing probes and sensors are essential for maintaining biopharmaceutical production's quality, safety, and efficiency. Consequently, their demand has risen in parallel with the growth of the biopharma industry.

The COVID-19 pandemic had a positive impact on the single-use probes & sensors market in 2020. The market has witnessed increased adoption of single-use probes and systems during the pandemic. The pandemic hastened the adoption of single-use solutions, including sensors, to fulfill the technological needs for therapeutic and vaccine production.

• For example, the April 2023 information mentioned by the American Pharmaceutical Review indicated a significant rise in the utilization of bioprocessing systems, which were of a single-use nature, after the onset of the pandemic for global biologics and vaccine production. Additionally, commercial-scale single-use bioprocessing systems experienced notable growth during COVID-19, rising from 32.5% in 2019 to 43.0% in 2022.

Therefore, the market growth was greatly enhanced by increased adoption of single-use bioprocessing systems during pandemics.

Segmentation

Key Insights

The following key insights are covered in the report:

• Number of Clinical Trials - by Key Countries/Sub-regions, 2022/2023


• New Product launches - by Key Players


• Key Industry Developments - Mergers, Acquisitions, and Partnerships


• Impact of COVID-19 on the Global Single Use Probes & Sensors Market

Analysis by Type

Based on the type, the market can be segmented into pH sensors/probes, pressure sensors/probes, temperature sensors/probes, conductivity sensors/probes, oxygen & CO₂ sensors/probes, flow sensors/probes, and others.

The pH sensors/probes segment is anticipated to hold a significant market share throughout the forecast period due to its widespread usage and highest availability.

• For instance, as per the data provided by the Pharmaceutical Bioprocessing Journal in January 2023, a pH probe is one of the most commonly used electrochemical sensors for bioprocess monitoring and control.

Therefore, market growth is expected to be driven by an increased use of pH sensors in bioreactors during the forecast period.

Moreover, the oxygen & CO₂ sensors/probes segment is projected to grow at a substantial CAGR during the forecast period. The growth of the segment is primarily due to the fact that dissolved oxygen (D.O.) level measurement is the physicochemical parameter monitored commonly in bioprocessing engineering. Several companies engaged in the manufacturing and launch of disposable sensors to measure D.O.

• For example, in October 2023, Hamilton Company announced the launch of VisiFerm SU, its redesign of dissolved oxygen sensors for single-use.

Furthermore, the others segment held a considerable market share in 2023, mainly due to the increasing demand for viable cell density sensors for cell density monitoring during the cell production process.

Regional Analysis

To gain extensive insights into the market, Request for Customization

Based on region, the single use probes and sensors market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for a significant market share in 2023 and is expected to exhibit significant CAGR throughout the forecast period. The growth of the region is mainly due to the presence of several biopharmaceutical manufacturers in the North American region.

In addition, Cardinal Health increased the capacity of its single-use device reprocessing facility in Riverview, Florida, to 100,000 square feet by November 2022. Therefore, due to these strategic expansions by market players, the demand for reprocessing of single-use probes and sensors is expected to increase, thereby driving market growth throughout the forecast period.

Furthermore, the Europe region accounted for a considerable market share in 2023. The regional growth is primarily attributed to the fact that some of the countries in the Asia Pacific region were recognized as a hub for biopharmaceutical outsourcing. Similarly, major industry players are focusing on expanding their presence into Asian countries.

• For instance, as per the data provided by Bioprocess International in December 2022, the China plant of Thermo Fisher Scientific, Inc. became the first single-use manufacturing site in Asia Pacific. The facility utilizes single-use bioreactors and equipment for the manufacturing of drug substances.

Key Players Covered

The report includes the profiles of key players, such as Hamilton Company, METTLER TOLEDO, Broadley-James Corporation, Aseptic Group, and Emerson Electric Co.

Key Industry Developments

• In September 2023, PyroScience GmbH announced the launch of its new pre-calibrated and pre-sterilized pH sensor systems for pH measurements.


• In June 2023, HPNE announced its partnership with Fannin to distribute its single-use products in the Irish market.


• In March 2021, METTLER TOLEDO acquired PendoTECH, a manufacturer and distributor of single-use sensors. This acquisition expanded METTLER TOLEDO’s presence in the single-use probe and sensors market.


• In March 2019, Pall Corporation and Broadley-James announced their partnership to integrate and distribute Broadley-James' advanced single-use probe and flow cell pH sensors.